Barrington Research Issues Pessimistic Forecast for Dolby Laboratories (NYSE:DLB) Stock Price

Dolby Laboratories (NYSE:DLB) had its price target decreased by investment analysts at Barrington Research from $95.00 to $90.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the electronics maker’s stock. Barrington Research’s price objective suggests a potential upside of 46.68% from the stock’s previous close.

Several other equities research analysts have also issued reports on the stock. Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Thursday, January 22nd. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday, January 5th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $90.75.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $61.36 on Monday. Dolby Laboratories has a 1 year low of $60.56 and a 1 year high of $89.66. The company has a market capitalization of $5.86 billion, a PE ratio of 23.33 and a beta of 0.88. The business has a fifty day moving average price of $65.27 and a two-hundred day moving average price of $69.05.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. During the same period in the previous year, the firm earned $0.61 EPS. The firm’s quarterly revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Sell-side analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Insider Activity at Dolby Laboratories

In other news, EVP Mark Andrew Sherman sold 9,109 shares of the firm’s stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $66.73, for a total transaction of $607,843.57. Following the sale, the executive vice president owned 73,054 shares in the company, valued at approximately $4,874,893.42. This trade represents a 11.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 36,699 shares of Dolby Laboratories stock in a transaction on Monday, November 24th. The stock was sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at $7,676,249.75. This represents a 24.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 137,120 shares of company stock worth $9,184,809 in the last 90 days. 37.93% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors have recently modified their holdings of DLB. Evergreen Capital Management LLC lifted its position in Dolby Laboratories by 40.6% in the 4th quarter. Evergreen Capital Management LLC now owns 6,336 shares of the electronics maker’s stock worth $407,000 after buying an additional 1,828 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Dolby Laboratories by 14.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,996 shares of the electronics maker’s stock worth $1,220,000 after acquiring an additional 2,400 shares during the last quarter. Asset Management One Co. Ltd. boosted its stake in shares of Dolby Laboratories by 2.4% in the 4th quarter. Asset Management One Co. Ltd. now owns 11,240 shares of the electronics maker’s stock valued at $732,000 after purchasing an additional 268 shares in the last quarter. Childress Capital Advisors LLC bought a new position in shares of Dolby Laboratories during the 4th quarter valued at $335,000. Finally, Farther Finance Advisors LLC raised its position in Dolby Laboratories by 48.4% in the 4th quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock worth $79,000 after purchasing an additional 402 shares during the period. 58.56% of the stock is currently owned by institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.